Matthew Babcock, PhD
Virginia Commonwealth University · University of Colorado, Denver
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Matthew Babcock, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:29 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07848828 · Autonomic and Renal Contributions to Hypertension With ADTVirginia Commonwealth University · recruiting · Androgen Deprivation Therapy, Prostate Cancer, Hypertension · principal investigator
- Ph4NCT05700903 · Contributions to Hypertension With Androgen Deprivation TherapyUniversity of Colorado, Denver · terminated · Androgen Deprivation Therapy, Prostate Cancer, Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Neural and Renal Contributions to Hypertension with Androgen Deprivation TherapyK01HL164978 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew C Babcock · fiscal years 2023 to 2026Named on NCT07848828
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.